Drug Profile
Research programme: monoclonal antibody therapeutics - BioInvent/Human Genome Sciences
Alternative Names: n-Co-DeR®Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator BioInvent International; Human Genome Sciences
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in USA (Parenteral)
- 03 Aug 2012 Human Genome Sciences has been acquired by GlaxoSmithKline
- 11 Mar 2010 Early research in Inflammation in USA (Parenteral)